tiprankstipranks
Trending News
More News >
Atyr Pharma Inc. (ATYR)
:ATYR
US Market

aTyr Pharma (ATYR) Income Statement

Compare
2,835 Followers

aTyr Pharma Income Statement

Last quarter (Q3 2025), aTyr Pharma's total revenue was $190.00K, an increase of Infinity% from the same quarter last year. In Q3, aTyr Pharma's net income was $-25.74M. See aTyr Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 235.00K$ 353.00K$ 10.39M$ 0.00$ 10.46M
Gross Profit
$ 235.00K$ 353.00K$ 8.69M$ -1.30M$ -6.84M
Operating Expenses
$ 68.15M$ 55.27M$ 55.09M$ 32.71M$ 9.07M
Depreciation and Amortization
$ 1.54M$ 2.74M$ 1.70M$ 1.30M$ 1.27M
EBITDA
$ -66.37M$ -52.18M$ -44.71M$ -32.47M$ -14.64M
Operating Income
$ -67.91M$ -54.92M$ -46.40M$ -34.02M$ -15.91M
Other Income/Expenses
$ 3.89M$ 4.52M$ 1.06M$ 238.00K$ -319.00K
Pretax Income
$ -64.02M$ -50.40M$ -45.34M$ -33.78M$ -16.23M
Net Income
$ -64.02M$ -50.39M$ -45.34M$ -33.77M$ -16.22M
Per Share Metrics
Basic EPS
$ -0.86$ -0.94$ -1.60$ -1.77$ -1.77
Diluted EPS
$ -0.86$ -0.94$ -1.60$ -1.77$ -1.77
Weighted Average Shares Outstanding
74.26M 53.61M 28.42M 19.08M 9.16M
Weighted Average Shares Outstanding (Diluted)
74.26M 53.61M 28.42M 19.08M 9.16M
Currency in USD

aTyr Pharma Earnings and Revenue History